Clinical Trial Update: Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin [Phase 3]

View source ↗

Summary

Clinical trial update for janagliflozin in adults with type 2 diabetes inadequately controlled with metformin (Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• janagliflozin (janagliflozin)

Snippet

Sponsor: Sihuan Pharmaceutical Holdings Group Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: UNKNOWN